Time point | Study period | |||||
---|---|---|---|---|---|---|
Enrolment | Allocation | Post-allocation | Follow-up | |||
−1 | 0 | 1–15 | 16 (12–20) | 17–24 | 34–54 | |
Research nurse assessment | X | X | X | |||
Informed consent | X | |||||
Eligibility assessment | X | |||||
Randomisation | x | |||||
Weekly follow-up by OAT staff (intervention group) | x | x | ||||
Clinical assessment | X | X | X | |||
CO-measurement | X | X | X | |||
Physical fitn. (4-min step-test) | X | X | X | |||
Full blood count, CRP* | X | X | X | |||
SCL-10 (mental health) | X | X | X | |||
FSS-3 (fatigue symptoms) | X | X | X | |||
EQ-5D-5L (quality of life) | X | X | X |